Company leader
Andy Olson
Co-Founder and CEO
Path Fertility / Inherent Biosciences
Olson co-founded Inherent Biosciences and Path Fertility to commercialize SpermQT beyond standard semen analysis.
Andy Olson is co-founder and chief executive of Inherent Biosciences, whose Path Fertility brand commercializes the SpermQT epigenetic sperm quality test.
Working with co-founder and chief scientific officer Kristin Brogaard, he has pushed clinic-channel adoption and employer fertility-benefit pathways for cases where standard semen analysis is inconclusive.
Public coverage describes an early-stage diagnostics company with modest current revenue and a roadmap centered on male reproductive health testing rather than consumer sperm storage kits.